glyburide has been researched along with Hemorrhage, Subarachnoid in 5 studies
Glyburide: An antidiabetic sulfonylurea derivative with actions like those of chlorpropamide
glyburide : An N-sulfonylurea that is acetohexamide in which the acetyl group is replaced by a 2-(5-chloro-2-methoxybenzamido)ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Glibenclamide reduced cerebral edema and mortality in a basic study of cerebral ischemia." | 1.91 | Glibenclamide reduces secondary brain injury in a SAH rat model by reducing brain swelling and modulating inflammatory response. ( Igarashi, T; Kajimoto, R; Moro, N; Oshima, H; Otani, N; Suma, T; Yoshino, A, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kajimoto, R | 1 |
| Igarashi, T | 1 |
| Moro, N | 1 |
| Oshima, H | 1 |
| Suma, T | 1 |
| Otani, N | 1 |
| Yoshino, A | 1 |
| da Costa, BBS | 1 |
| Windlin, IC | 1 |
| Koterba, E | 1 |
| Yamaki, VN | 1 |
| Rabelo, NN | 1 |
| Solla, DJF | 1 |
| Teixeira, MJ | 1 |
| Figueiredo, EG | 1 |
| Tosun, C | 2 |
| Kurland, DB | 1 |
| Mehta, R | 1 |
| Castellani, RJ | 1 |
| deJong, JL | 1 |
| Kwon, MS | 1 |
| Woo, SK | 2 |
| Gerzanich, V | 2 |
| Simard, JM | 2 |
| Geng, Z | 1 |
| Ivanova, S | 1 |
| Melnichenko, L | 1 |
| Onoue, H | 1 |
| Katusic, ZS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Glibenclamide in Aneurysmatic Subarachnoid Hemorrhage: A Prospective and Randomized Study[NCT03569540] | Phase 4 | 50 participants (Anticipated) | Interventional | 2018-07-03 | Recruiting | ||
| A Blind-adjudication Multi-center Phase II Randomized Clinical Trial of Continuous Low-dose Intravenous Heparin Therapy in Coiled Low-grade Aneurysmal Subarachnoid Hemorrhage Patients With Significant Hemorrhage Burden[NCT02501434] | Phase 2 | 88 participants (Anticipated) | Interventional | 2016-04-30 | Suspended | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for glyburide and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Brain; Brazil; Cognition; Double-Blind Method; Female; Glyburide; Humans; M | 2019 |
4 other studies available for glyburide and Hemorrhage, Subarachnoid
| Article | Year |
|---|---|
Glibenclamide reduces secondary brain injury in a SAH rat model by reducing brain swelling and modulating inflammatory response.
Topics: Animals; Brain Edema; Brain Injuries; Brain Neoplasms; Cytokines; Endothelial Cells; Glyburide; Rats | 2023 |
Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage.
Topics: Animals; Brain; Cognition Disorders; Encephalitis; Glyburide; Humans; Maze Learning; Rats; Subarachn | 2013 |
Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage.
Topics: Animals; ATP-Binding Cassette Transporters; Blood-Brain Barrier; Brain Edema; Carotid Artery Injurie | 2009 |
The effect of subarachnoid hemorrhage on mechanisms of vasodilation mediated by cyclic adenosine monophosphate.
Topics: 4-Aminopyridine; Adenylyl Cyclases; Animals; Basilar Artery; Charybdotoxin; Colforsin; Cyclic AMP; D | 1998 |